Targeting the Hippo Transducer TAZ in Breast Cancer With Statins
NCT02416427
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
Atorvastatin
Sponsor
Regina Elena Cancer Institute